Sec Form 4 Filing - Furlow Brenda S. @ BIO-TECHNE Corp - 2020-05-28

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
Furlow Brenda S.
2. Issuer Name and Ticker or Trading Symbol
BIO-TECHNE Corp [ TECH]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
X __ Officer (give title below) _____ Other (specify below)
SVP - General Counsel
(Last) (First) (Middle)
614 MCKINLEY PLACE NE
3. Date of Earliest Transaction (MM/DD/YY)
05/28/2020
(Street)
MINNEAPOLIS, MN55413
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 05/28/2020 M 5,995 A $ 108.49 8,706 D
Common Stock 05/28/2020 M 1,600 A $ 94.35 10,306 D
Common Stock 05/28/2020 S 2,195 D $ 259.7172 ( 1 ) 8,111 D
Common Stock 05/28/2020 S 3,800 D $ 260.3825 ( 2 ) 4,311 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) $ 94.35 05/28/2020 M 1,600 ( 4 ) 08/12/2021 Common Stock 1,600 $ 0 0 D
Stock Options (Right to Buy) $ 108.49 05/28/2020 M 5,995 ( 4 ) 08/07/2022 Common Stock 5,995 $ 0 10,000 D
Stock Options (Right to Buy) $ 106.59 ( 4 ) 08/18/2023 Common Stock 10,857 10,857 D
Stock Options (Right to Buy) $ 106.59 ( 8 ) 08/18/2023 Common Stock 14,476 14,476 D
Restricted Stock Units ( 3 ) ( 11 ) ( 11 ) Common Stock 1,724 1,724 D
Stock Options (Right to Buy) $ 125.05 ( 11 ) 08/09/2024 Common Stock 9,503 9,503 D
Stock Options (Right to Buy) $ 125.05 ( 6 ) 08/09/2024 Common Stock 12,670 12,670 D
Restricted Stock Units ( 3 ) ( 10 ) ( 10 ) Common Stock 1,374 1,374 D
Stock Options (Right to Buy) $ 177.32 ( 10 ) 08/08/2025 Common Stock 7,339 7,339 D
Stock Options (Right to Buy) $ 177.32 ( 5 ) 08/08/2025 Common Stock 9,786 9,786 D
Restricted Stock Units ( 3 ) ( 9 ) ( 9 ) Common Stock 1,969 1,969 D
Stock Options (Right to Buy) $ 190.41 ( 9 ) 08/07/2026 Common Stock 9,968 9,968 D
Stock Options (Right to Buy) $ 190.41 ( 7 ) 08/07/2026 Common Stock 13,290 13,290 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Furlow Brenda S.
614 MCKINLEY PLACE NE
MINNEAPOLIS, MN55413
SVP - General Counsel
Signatures
/s/ Andrew Nick as Attorney-in-Fact for Brenda S. Furlow pursuant to Power of Attorney previously filed. 06/01/2020
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $259.0500 to $260.0400, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
( 2 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $260.0800 to $261.0400, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
( 3 )Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
( 4 )Fully exercisable.
( 5 )Options to purchase 2,447 shares vest on each of 8/8/2019 and 8/8/2020 and options to purchase 2,446 shares vest on each of 8/8/2021 and 8/8/2022.
( 6 )Options to purchase 3,167 shares vest on each of 8/9/2018 and 8/9/2019 and options to purchase 3,168 shares vest on each of 8/9/2020 and 8/9/2021.
( 7 )Options to purchase 3,323 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 3,322 shares vest on each of 8/7/2022 and 8/7/2023.
( 8 )Options to purchase 3,619 shares vest on each of 8/18/2017, 8/18/2018, 8/18/2019 and 8/18/2020.
( 9 )Vests in full or in part on 8/7/2022 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
( 10 )Vests in full or in part on 8/8/2021 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
( 11 )Vests in full or in part on 8/9/2020 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.